These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20881042)

  • 1. Peptide inhibitors of flavivirus entry derived from the E protein stem.
    Schmidt AG; Yang PL; Harrison SC
    J Virol; 2010 Dec; 84(24):12549-54. PubMed ID: 20881042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule inhibitors of dengue-virus entry.
    Schmidt AG; Lee K; Yang PL; Harrison SC
    PLoS Pathog; 2012; 8(4):e1002627. PubMed ID: 22496653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide inhibitors of dengue virus and West Nile virus infectivity.
    Hrobowski YM; Garry RF; Michael SF
    Virol J; 2005 Jun; 2():49. PubMed ID: 15927084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate.
    Schmidt AG; Yang PL; Harrison SC
    PLoS Pathog; 2010 Apr; 6(4):e1000851. PubMed ID: 20386713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the mode of action of a potent dengue virus capsid inhibitor.
    Scaturro P; Trist IM; Paul D; Kumar A; Acosta EG; Byrd CM; Jordan R; Brancale A; Bartenschlager R
    J Virol; 2014 Oct; 88(19):11540-55. PubMed ID: 25056895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
    Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of dengue virus genome induced by a peptide inhibitor.
    Lok SM; Costin JM; Hrobowski YM; Hoffmann AR; Rowe DK; Kukkaro P; Holdaway H; Chipman P; Fontaine KA; Holbrook MR; Garry RF; Kostyuchenko V; Wimley WC; Isern S; Rossmann MG; Michael SF
    PLoS One; 2012; 7(11):e50995. PubMed ID: 23226444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
    de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
    Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate-related inhibitors of dengue virus entry.
    Hidari KI; Abe T; Suzuki T
    Viruses; 2013 Feb; 5(2):605-18. PubMed ID: 23389466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.
    Alhoot MA; Rathinam AK; Wang SM; Manikam R; Sekaran SD
    Int J Med Sci; 2013; 10(6):719-29. PubMed ID: 23630436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion.
    Yamamoto M; Ichinohe T; Watanabe A; Kobayashi A; Zhang R; Song J; Kawaguchi Y; Matsuda Z; Inoue JI
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33371476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel target sites and an inhibitor of the dengue virus E protein.
    Yennamalli R; Subbarao N; Kampmann T; McGeary RP; Young PR; Kobe B
    J Comput Aided Mol Des; 2009 Jun; 23(6):333-41. PubMed ID: 19241120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide inhibitors against dengue virus infection.
    Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
    Yang CC; Hu HS; Lin HM; Wu PS; Wu RH; Tian JN; Wu SH; Tsou LK; Song JS; Chen HW; Chern JH; Chen CT; Yueh A
    Antiviral Res; 2019 Dec; 172():104636. PubMed ID: 31654671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
    Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
    ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of small GTPase Rac1 in the regulation of actin cytoskeleton during dengue virus infection.
    Wang JL; Zhang JL; Chen W; Xu XF; Gao N; Fan DY; An J
    PLoS Negl Trop Dis; 2010 Aug; 4(8):. PubMed ID: 20824170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Aspects of the Dengue Virus Infection Process: A Review.
    Zonetti LFC; Coutinho MC; de Araujo AS
    Protein Pept Lett; 2018; 25(8):712-719. PubMed ID: 29984641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry.
    Chin JF; Chu JJ; Ng ML
    Microbes Infect; 2007 Jan; 9(1):1-6. PubMed ID: 17196419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion.
    Butrapet S; Childers T; Moss KJ; Erb SM; Luy BE; Calvert AE; Blair CD; Roehrig JT; Huang CY
    Virology; 2011 Apr; 413(1):118-27. PubMed ID: 21353281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the identification of dengue virus entry/fusion inhibitors.
    De La Guardia C; Lleonart R
    Biomed Res Int; 2014; 2014():825039. PubMed ID: 25157370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.